Mouse Embryonic Stem (ES) cells are derived from the Inner Cell Mass (ICM) just prior to implantation into the uterus. In the embryo, they are pluripotent, i.e. they give rise to all cell types of the adult organism. When maintained in specific culture conditions, ES cells propagate essentially indefinitely as pluripotent cells in vitro, a property called self-renewal. As a result, ES cells are a useful system for understanding the mechanisms that promote pluripotency versus lineage commitment in the embryo and have become essential to studies of embryonic development and regeneration. Many studies have examined the transcriptional, epigenetic, and signaling programs that contribute to ES cell self-renewal. Growing evidence suggests that the ubiquitin- proteasome system (UPS) also reinforces ES cell identity. The UPS consists of a network of ubiquitin ligases, enzymes that add ubiquitin to substrates; deubiquitinases (DUBs), which oppose the actions of ubiquitin ligases; and the proteasome, which degrades ubiquitinated proteins. The contributions of DUBs to pluripotency are still poorly understood, despite several examples of DUBs promoting self-renewal. In preliminary studies, we have found that the DUB Usp9x promotes the open chromatin state and self-renewal capacity of ES cells. We propose to study this protein in mouse ES cells and will test the hypothesis that Usp9x is an important regulator of ES cell identity, promoting self-renewal by deubiquitinating and stabilizing key components of self- renewal pathways. Specifically, we aim to dissect the role(s) of Usp9x in mouse ES cells by (1) analyzing the consequences of Usp9x genetic deletion and mutation on ES cell self renewal and lineage induction (2) and by identifying key substrates and interacting partners. This work aims to shed light on the interplay between the ubiquitin-proteasome system and self-renewal programs. It is highly relevant to studies of molecular mechanisms underlying intellectual and developmental disability and has the potential to offer insight into how USP9X deregulation promotes human developmental disorders, neurological syndromes, and cancer.

Public Health Relevance

Embryonic Stem (ES) cells have become an essential model system for studies of embryonic development, regenerative medicine, and stem cell therapies due to their ability to differentiate into all cell types of the body. We propose to study how the deubiquitinating enzyme Usp9x regulates ES cell identity and differentiation. This project is highly relevant to our understanding of human development and disease, as mutations in USP9X have been identified in a range of human neurological disorders, developmental syndromes, and cancers.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Individual Predoctoral NRSA for M.D./Ph.D. Fellowships (ADAMHA) (F30)
Project #
5F30HD093116-02
Application #
9601591
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Mukhopadhyay, Mahua
Project Start
2017-08-01
Project End
2022-07-31
Budget Start
2018-08-01
Budget End
2019-07-31
Support Year
2
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94118
Bulut-Karslioglu, Aydan; Macrae, Trisha A; Oses-Prieto, Juan A et al. (2018) The Transcriptionally Permissive Chromatin State of Embryonic Stem Cells Is Acutely Tuned to Translational Output. Cell Stem Cell 22:369-383.e8